Bevacizumab better for tumor imaging than Gold Standard Imaging

A new compound, Cu-64 labeled bevacizumab is claimed to be better than FDG which is considered gold standard for PET imaging. Bevacizumab, an anticancer agent is an antibody that targets vascular endothelial growth factor (VEGF), a signaling protein involved in angiogenesis. Follow the link below for details.
For Tumor Detection Bevacizumab Better Than Gold Standard Imaging